A Heart of Goodwill · The Joyful Remedy Fethiann Our team believes that true healing comes from the wisdom of nature and the warmth of science. Guided by a “heart of goodwill,” we delve into the potential of Taiwan’s rare plants, integrating herbal wisdom with Western science to develop functional ingredients and care formulas that are gentle, effective, and aligned with people’s needs. Our specialized Floral Extract Molecular Laboratory focuses on Taiwan’s native plants—such as Litsea cubeba (Taiwan Magao) and Michelia alba—and has successfully developed three patented core technologies: • FMO® – High-Efficacy API from Michelia alba (Fumon) • FLC® – High-Efficacy API from Taiwan Magao • Molecurique® – Floral Extract Molecular Repair Platform These patented ingredients have been applied in both domestic and international markets for the relief of muscle and joint discomfort, itch reduction, skin repair, wound healing, and metabolic regulation. They have passed multiple clinical validations and have earned high recognition from leading medical centers and clients worldwide. We not only safeguard the value of Taiwan’s plants but also bring them to the world: • In October 2023, FMO® passed the review of the Personal Care Products Council (PCPC) in the United States, successfully obtaining global INCI registration (ID 38556) and entering the supply chain of international brands. • In January 2024, FMO® obtained certification from Australia’s Therapeutic Goods Administration (TGA) (ID 147865), becoming the first Taiwan-based Michelia alba ingredient developer to meet TGA standards, while also being recognized by over 20 PIC/S international pharmaceutical regulatory member countries. Today, our products are distributed in Australia, Japan, Singapore, Thailand, Malaysia, and beyond. We are continuing to expand into Europe and North America—bringing the natural healing power of Taiwan into the daily lives of people worldwide who value health and nature.